Stromal senescence and response to immune checkpoint inhibition in melanoma

被引：0
|
作者：
Sojo, Giselle Burton
Schmidt, Marcel O.
机构：
来源：
CANCER IMMUNOLOGY RESEARCH | 2025年 / 13卷 / 02期
关键词：
D O I：
10.1158/2326-6074.IO2025-B047
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B047
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Stromal reprogramming by FAK inhibition overcomes radiation resistance to allow for immune priming and response to checkpoint blockade.
    Lander, Varintra E.
    Belle, Jad I.
    Knolhoff, Brett L.
    Herndon, John M.
    Mpoy, Cedric
    Rogers, Buck E.
    Schwarz, Julie K.
    DeNardo, David G.
    CANCER RESEARCH, 2021, 81 (22) : 76 - 77
  • [42] Immune profiling of metastatic uveal melanoma and response to immune checkpoint inhibitors.
    Shao, Yusra F.
    Baca, Yasmine
    Xiu, Joanne
    Vanderwalde, Ari M.
    In, Gino Kim
    Hoon, Dave S. B.
    Domingo-Musibay, Evidio
    Darabi, Sourat
    Eisenberg, Burton Larry
    Sato, Takami
    Gibney, Geoffrey Thomas
    Mamdani, Hirva
    Moser, Justin C.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [43] Melanoma gene signature defines response to immune checkpoint inhibitors
    Seebacher, Nicole
    Stacy, Alexandra
    Jansson, Patric
    Middleton, Mark
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 79 - 79
  • [44] Biomarkers Predictive of Survival and Response to Immune Checkpoint Inhibitors in Melanoma
    Rizk, Emanuelle M.
    Seffens, Angelina M.
    Trager, Megan H.
    Moore, Michael R.
    Geskin, Larisa J.
    Gartrell-Corrado, Robyn D.
    Wong, Winston
    Saenger, Yvonne M.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2020, 21 (01) : 1 - 11
  • [45] Long-Term Outcomes of Immune Checkpoint Inhibition in Metastatic Melanoma
    Francesca Aroldi
    Mark R. Middleton
    American Journal of Clinical Dermatology, 2022, 23 : 331 - 338
  • [46] Long-Term Outcomes of Immune Checkpoint Inhibition in Metastatic Melanoma
    Aroldi, Francesca
    Middleton, Mark R.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2022, 23 (03) : 331 - 338
  • [47] Sarcoidosis developing upon immune checkpoint inhibition in advanced uveal melanoma
    Franziska Grän
    Judith Weber
    Patrick Schummer
    Hermann Kneitz
    Matthias Goebeler
    Anette Thurner
    Anja Gesierich
    European Journal of Dermatology, 2020, 30 : 629 - 631
  • [48] Biological Factors behind Melanoma Response to Immune Checkpoint Inhibitors
    Olbryt, Magdalena
    Rajczykowski, Marcin
    Widlak, Wieslawa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (11) : 1 - 20
  • [49] Biomarkers Predictive of Survival and Response to Immune Checkpoint Inhibitors in Melanoma
    Emanuelle M. Rizk
    Angelina M. Seffens
    Megan H. Trager
    Michael R. Moore
    Larisa J. Geskin
    Robyn D. Gartrell-Corrado
    Winston Wong
    Yvonne M. Saenger
    American Journal of Clinical Dermatology, 2020, 21 : 1 - 11
  • [50] Peripheral blood biomarkers in immune checkpoint inhibition therapy in metastatic melanoma
    Ghelani, Ghanshyam H.
    Mandava, Anupa
    Zerdan, Maroun Bou
    Mehta, Radhika
    Sivapiragasam, Abirami
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345